| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anesthesia and the Developing Brain: A Review of Sevoflurane-induced Neurotoxicity in Pediatric Populations
|
Apai, Carol
|
|
|
43 |
4 |
p. 762-778
|
artikel
|
| 2 |
A Survey of Practices in the United States Regarding Hepatitis C Screening in Pregnant Women
|
Godar, Elizabeth A.
|
|
|
43 |
4 |
p. 780-784
|
artikel
|
| 3 |
Corrigendum to “Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study” [Clin Therapeut 42 (12) (2020) 2254–2265]
|
Smith, Timothy R.
|
|
|
43 |
4 |
p. 791
|
artikel
|
| 4 |
Corrigendum to “Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency” [Clin Therapeut 42(9) 1799-1810]
|
Du, Pengqiang
|
|
|
43 |
4 |
p. 790
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
43 |
4 |
p. ii-iii
|
artikel
|
| 6 |
Effectiveness, Safety, and Adherence to Treatment of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Real Practice
|
Gayoso-Rey, Mónica
|
|
|
43 |
4 |
p. e111-e121
|
artikel
|
| 7 |
How Health Care Systems Can Advance Therapeutics
|
Maron, Jill L.
|
|
|
43 |
4 |
p. 651-652
|
artikel
|
| 8 |
Impact of SLCO4C1 Genotypes, Creatinine, and Spironolactone on Digoxin Population Pharmacokinetic Variables in Patients With Cardiac Insufficiency
|
Du, Pengqiang
|
|
|
43 |
4 |
p. 788
|
artikel
|
| 9 |
Inpatient Omission of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With Morbidity and Mortality in Coronavirus Disease 2019
|
Oddy, Christopher
|
|
|
43 |
4 |
p. e97-e110
|
artikel
|
| 10 |
In response to Du et al., 2020, 42(9):1799-1810
|
Walson, Philip D.
|
|
|
43 |
4 |
p. 786-787
|
artikel
|
| 11 |
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic
|
Alfadhli, Eman M.
|
|
|
43 |
4 |
p. 711-719
|
artikel
|
| 12 |
Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial
|
Nasser, Azmi
|
|
|
43 |
4 |
p. 684-700
|
artikel
|
| 13 |
Pharmacokinetic Interactions between Tegoprazan and Metronidazole/Tetracycline/Bismuth and Safety Assessment in Healthy Korean Male Subjects
|
Jeon, Ji-Young
|
|
|
43 |
4 |
p. 722-734
|
artikel
|
| 14 |
Pharmacokinetics of FT218, a Once-Nightly Sodium Oxybate Formulation in Healthy Adults
|
Seiden, David
|
|
|
43 |
4 |
p. 672.e1-672.e14
|
artikel
|
| 15 |
Rational Use of Lasmiditan for Acute Migraine Treatment in Adults: A Narrative Review
|
Ferrari, Anna
|
|
|
43 |
4 |
p. 654-670
|
artikel
|
| 16 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SPH3127: A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial
|
Jing, Shan
|
|
|
43 |
4 |
p. 735.e1-735.e14
|
artikel
|
| 17 |
Table of Contents
|
|
|
|
43 |
4 |
p. iv-v
|
artikel
|
| 18 |
The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the World
|
Jhaveri, Ravi
|
|
|
43 |
4 |
p. 702-710
|
artikel
|
| 19 |
Value of Growth/Differentiation Factor 15 in Diagnosis and the Evaluation of Chemotherapeutic Response in Lung Cancer
|
Deng, Jingjing
|
|
|
43 |
4 |
p. 747-759
|
artikel
|
Tijdschrift beschrijving